<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000774803"><TermName>COPDAC regimen</TermName><TermPronunciation>(… REH-jih-men)</TermPronunciation><TermDefinition><DefinitionText>An abbreviation for a chemotherapy combination that is often used with radiation therapy to treat certain types of childhood Hodgkin lymphoma in males. It includes the drugs cyclophosphamide, vincristine sulfate (Oncovin), prednisone, and dacarbazine. Also called COPDAC.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000776442" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;COPDAC regimen&quot;" language="en" id="_3"/><MediaLink ref="CDR0000776443" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen COPDAC&quot;" language="es" id="_4"/><SpanishTermName>régimen COPDAC</SpanishTermName><SpanishTermDefinition><DefinitionText>Sigla del nombre de una quimioterapia combinada que a menudo se usa con la radioterapia para tratar varones con  determinados tipos de linfoma de Hodgkin infantil. Esto incluye los medicamentos ciclofosfamida, sulfato de vincristina (Oncovin), prednisona y dacarbazina. También se llama COPDAC.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2015-09-11</DateFirstPublished><RelatedInformation><RelatedDrugSummaryRef href="CDR0000775347">COPDAC</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
